首都医科大学学报 ›› 2012, Vol. 33 ›› Issue (6): 803-809.doi: 10.3969/j.issn.1006-7795.2012.06.020

• 临床研究 • 上一篇    下一篇

瑞舒伐他汀对晚期内皮祖细胞增生、迁移及凋亡的影响

盛瑾, 刘文娴, 李鹏   

  1. 首都医科大学附属北京安贞医院心内科监护室, 北京 100029
  • 收稿日期:2012-06-14 修回日期:1900-01-01 出版日期:2012-12-21 发布日期:2012-12-21
  • 通讯作者: 刘文娴

Effects of rosuvastatin on the proliferation, migration and apoptosis of late endothelial progenitor cells

SHENG Jin, LIU Wenxian, LI Peng   

  1. Division of Cardiologic Intensive Care Unit, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
  • Received:2012-06-14 Revised:1900-01-01 Online:2012-12-21 Published:2012-12-21

摘要: 目的 观察不同浓度及不同时间的瑞舒伐他汀(rosuvastatin)对晚期内皮祖细胞(endothelial progenitor cells,EPCs)增生(proliferation)、迁移(migration)和凋亡(apoptosis)的影响。方法 采用密度梯度法从大鼠骨髓获取单个核细胞,培养28 d,通过FITC-UEA-I和DiI-acLDL双染色鉴定为正分化晚期EPCs。以不同浓度的瑞舒伐他汀(0.001、0.01、0.1、 1.0、10、100 μmol/L)和晚期EPCs共培养24 h,分别采用MTT比色法、Transwell小室及Tunel法检测其增生、迁移及凋亡功能;以浓度为0.1 μmol/L的瑞舒伐他汀与晚期EPCs分别共培养1、3、6、12、24、48 h,应用同样方法检测其增生、迁移及凋亡功能。结果 体外培养7 d时,细胞呈典型长梭形;28 d时,呈铺路石样,并可摄取FITC-UEA-I和DiI-acLDL。不同浓度的瑞舒伐他汀组与对照组相比均可明显地改善晚期EPCs的增生(P<0.05)、迁移(P<0.05)及凋亡(P<0.05)功能,且浓度为0.1 μmol/L的瑞舒伐他汀改善细胞功能最强(P<0.05)。当瑞舒伐他汀浓度为0.1 μmol/L、共培养不同时间后,与对照组相比可增强晚期EPCs的增生(P<0.05)、迁移(P<0.05)及抗凋亡(P<0.05)功能。结论 瑞舒伐他汀能够提高晚期内皮祖细胞的增生、迁移功能,减少细胞的凋亡,且呈浓度及时间依赖性。

关键词: 晚期内皮祖细胞, 瑞舒伐他汀, 增生, 迁移, 凋亡

Abstract: Objective To evaluate the effect of rosuvastatin on the proliferation, migration and apoptosis of late endothelial progenitor cells(EPCs) from bone marrow of rats. Methods The late EPCs were cultured and characterized by DiLDLuptake and lectin binding. Then, we co-cultured the EPCs with culture medium containing rosuvastatin of different concentrations(0.001, 0.01, 0.1, 1.0, 10, 100 μmol/L), and tested the proliferation, migration and apoptosis; furthermore, we co-cultured EPCs with medium containing 0.1 μmol/L rosuvastatin for different hours(1, 3, 6, 12, 24, 48 h), and the functions including proliferation, migration and apoptosis were analyzed again. Results The early EPCs became long spindle on the seventh day, and then became cornerstone shape on the 28th day. Moreover, late EPCs can take in Dil-acLDL and FITC-UEA-I. After co-cultured with rosuvastatin of different concentrations, it was demonstrated that proliferation(P<0.05), migration(P<0.05) and apoptosis(P<0.05) were improved. Furthermore, compared with the control, the protection was highest when the rosuvastatin concentration was 0.1 μmol/L. It was also found that proliferation(P<0.05), migration(P<0.05) and apoptosis(P<0.05) of late EPCs were improved at the concentration of 0.1 μmol/L rosuvastatin, and the protection increased with time, but did not changed significantly after 24 hours. Conclusion This study demonstrated that rosuvastatin could improve the proliferation, migration and apoptosis of late EPCs from bone marrow in concentration- and time-dependent manner.

Key words: late endothelial progenitor cells, rosuvastatin, proliferation, migration, apoptosis

中图分类号: